IBI188 Combination Therapy in Solid Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ba Yi
Tianjin Medical University Cancer Institute and Hospital
Principal Investigator - Fang Meiyu
Zhejiang Cancer Hospital
Principal Investigator - Guo Hongqian
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Principal Investigator - Guo Wei
Peking Union Medical College
Principal Investigator - Li Xiangping
Nanfang Hospital, Southern Medical University
Principal Investigator - Liu Guihong
The Affiliated Hospital of Xuzhou Medical University
Principal Investigator - Liu Jisheng
First Affiliated Hospital of Soochow University
Principal Investigator - Lv Qiang
Jiangsu Provincial People's Hospital
Principal Investigator - Mou Weiqi
Chongqing University Cancer Hospital
Principal Investigator - Wang Haiying
Shougang Hospital, Peking University
Principal Investigator - Wang Mengzhao
Shougang Hospital, Peking University
Principal Investigator - Wang Wei
Hunan Cancer Hospital
Principal Investigator - Wang Ying
Zhejiang Provincial People's Hospital
Principal Investigator - Xie Yu
Hunan Cancer Hospital
Principal Investigator - Xu Chongyuan
Nanfang Hospital, Southern Medical University
Principal Investigator - Zhang Dahong
Zhejiang Provincial People's Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Tianjin Medical University Cancer Institute and Hospital
Tianjin, China
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 25 May 2021
- Primary completion
- 30 Jul 2022
- Completion
- 30 Jul 2022
- Last update posted
- 4 Oct 2022
- Registered enrollment
- 9
- Registry id
- NCT04861948
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.